GlassScriptPhysician profile
Darren B Barbacci
NPI 1770578387
$20,111.47
in general payments reported to CMS, 2019-2025
11 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2021: $2,061 · 2022: $280 · 2023: $89.35 · 2024: $477 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $16K · Food and Beverage: $1,451 · Travel and Lodging: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $15,925.00 |
| Food and Beverage | $1,450.74 |
| Travel and Lodging | $261.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $15,936.83 | 2019-2025 | |
| Treace Medical Concepts, INC. | $3,171.07 | 2021-2025 | |
| Smith+Nephew, INC. | $366.10 | 2022-2025 | Grafix Pl, Oasis, Stravix |
| Paratek Pharmaceuticals, INC. | $189.96 | 2021 | |
| Paragon 28, INC. | $121.91 | 2023-2024 | Mtp, Tenotac 2.0 |
| Melinta Therapeutics, LLC | $104.75 | 2019 | |
| Aroa Biosurgery Incorporated | $89.67 | 2024 | |
| Solventum Corporation | $46.57 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Integra Lifesciences Corporation | $45.62 | 2022 | |
| Novus Surgical Consultants | $21.27 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Barbacci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.